HFrEF Treatment

5.0(2)
studied byStudied by 3 people
5.0(2)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/93

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

94 Terms

1
New cards

What is the general approach for initiating drugs in HFrEF

Initiate as many mortality reducing drugs as the patient can tolerate and then titrate up to target doses

2
New cards

Which decreases mortality in HF patients the most: adding a new class of medication or increasing the dose of the medications they are on?

Adding a new class of medications

3
New cards

What gives the most mortality reduction in HF patients?

Target doses of all GDMTs!!

4
New cards

If a patient is newly diagnosed with HFrEF when should they achieve maximally tolerated or target doses of GDMT medications?

3 months

5
New cards

If a patient is discharged from the hospital for HFrEF when should they achieve maximally tolerated or target doses of GDMT medications?

6 weeks

6
New cards

Which medication classes should be given to a heart failure patient first?

ARNI (or ACEi/ARB), Beta-blocker, MRA, and SGLT inhibitors

7
New cards

When should a HFrEF patient be put on a diuretic (loop diuretic)?

if they are experiencing persistent volume overload (any signs of congestion/hypervolemia) even after taking max doses of GDMT meds

8
New cards

When should a HFrEF patient be put on hydralazine/isosorbide dinitrate?

If they are an African American that is persistently symptomatic and on other GDMT meds

9
New cards

When should a HFrEF patient be put on ivabradine?

Patients with a resting HR >= 70 bpm on maximally tolerated beta-blocker and in sinus rhythm (may or may not have symptoms)

10
New cards

When should a HFrEF patient be put on vericiguat?

patients on GDMT meds with worsening HF evidenced by HF hospitalization or requirement for IV diuretics

11
New cards

After starting Entresto what should be assessed in 1-2 weeks?

tolerability, BP, electrolytes, and renal function

12
New cards

When do you increase the dose of Entresto?

every 1-2 weeks increase the dose stepwise to a target of 97/103 mg twice a day

13
New cards

Which patients start on the lower dose of Entresto?

patients already on a daily equivalent of <= 10 mg enalapril or <= 160 mg valsartan, ACEi/ARB naive, eGFR < 30 mL/min/1.73m2, >= 75 years old

14
New cards

Which patients start on the higher dose of Entresto?

On equivalent of > 10 mg of enalapril or > 160 mg valsartan

15
New cards

When should a HF patient get an ACEi/ARB instead of an ARNI?

if the patient is not able to get/take Entresto for various reasons.

16
New cards

what should be assessed in 1-2 weeks after starting an ACEi/ARB

tolerability. BP, electrolytes, renal function

17
New cards

When do you increase the dose of an ACEi/ARB in patients with HFrEF

every 1-2 weeks and increase the dose stepwise to target doses

18
New cards

What are the starting dose options for sacubitril/valsartan

24/26 mg or 49/51 mg twice a day

19
New cards

What are the starting dose options for lisinopril

2.5-5 mg once a day

20
New cards

What are the starting dose options for valsartan

40 mg twice daily

21
New cards

What is the target dose for sacubitril/valsartan

97/103 mg twice daily

22
New cards

What is the target dose for lisinopril

20-40 mg daily

23
New cards

What is the target dose for valsartan

160 mg twice daily

24
New cards

How many days do you wait to assess tolerability, BP, electrolytes, and renal function in patients starting an MRA?

in 7 days

25
New cards

When do you increase the dose for MRAs

increase the dose stepwise at least every 2 weeks to target dosing and monitoring appropriately

26
New cards

Contraindications for MRAs in HFrEF

eGFR < 30 mL/min/1.73m2 or creatinine > 2.5 mg/dL in men and creatinine > 2 mg/dL in women

27
New cards

Special monitoring for MRAs in HFrEF

electrolytes and renal function 7 days after initiation/titration - after a stable dose check these monthly for 3 months and then every 3 months out to a year

28
New cards

Starting dose for spironolactone

12.5-25 mg once daily

29
New cards

Target dose for spironolactone

25-50 mg once daily

30
New cards

How do the doses of MRAs differ for heart failure compared to patients with HTN?

The doses are lower than what is generally used for HTN

31
New cards

Which SGLT inhibitors do you have to check that the patients eGFR is >= 25 g/mL/1.73m2?

dapagliflozin and sotagliflozin

32
New cards

when do you increase the dose of sotagliflozin

increase the dose stepwise to the target dosing in 2 weeks

33
New cards

Contraindications for SGLT inhibitors

Patients with type I diabetes

34
New cards

Starting dose for dapagliflozin

10 mg once daily

35
New cards

Starting dose for empagliflozin

10 mg daily

36
New cards

Target dose for dapagliflozin

10 mg daily <3

37
New cards

Target dose for empagliflozin

10 mg once a day

38
New cards

Can empagliflozin and dapagliflozin be titrated up from 10 mg?

Yes, if concomitant diabetes for glucose control

39
New cards

starting dose of sotagliflozin

200 mg daily

40
New cards

target dose of sotagliflozin

400 mg daily

41
New cards

What needs to be monitored when using beta-blockers in HFrEF

monitor HR and BP after initiation and during titration

42
New cards

When do you increase the dose of beta-blockers in HF

increase the dose every 2 weeks stepwise to target dosing

43
New cards

starting dose of bisoprolol

2.5 mg daily

44
New cards

target dose of bisoprolol

10 mg daily

45
New cards

starting dose of metoprolol succinate

12.5-25 mg once a day

46
New cards

target dose of metoprolol succinate

200mg daily

47
New cards

Starting dose of carvedilol

3.125-6.25 mg twice daily

48
New cards

target dose of carvedilol

25 mg twice daily

if > 85 kg give patient 50 mg twice daily

49
New cards

What to monitor after giving loop diuretics?

bp, electrolytes, and renal function after initiation and during titration!

50
New cards

When do you titrate the dose of loop diuretics?

titrate to relief of congestion which may be over days or weeks - increase as needed to maintain euvolemia and to

51
New cards

What is the usual start dose of furosemide?

~20-40 mg orally

52
New cards

Why are frequent clinic visits needed for loop diuretics

Need frequent clinic visits until patient is titrated to optimal effect, and may need to prescribe PO potassium in conjunction

53
New cards

If patients have increased distal sodium reabsorption from chronic loop diuretic use what med can be added on?

A thiazide

54
New cards

If a patient has poor delivery of the loop diuretic to the site of effect due to reduced GFR, HF, or gut edema, what can be done?

Increase the dose of loop diuretic

55
New cards

Furosemide 20 mg IV is equivalent to what dose orally?

40 mg

56
New cards

Furosemide 20 mg IV is equivalent to what dose of IV torsemide?

20 mg

57
New cards

Furosemide 20 mg IV is equivalent to what dose of IV bumetanide

1 mg

58
New cards

Furosemide 20 mg IV is equivalent to what dose of IV ethacrynic acid

50 mg

59
New cards

Furosemide 40 mg orally is equivalent to what dose of oral torsemide

20 mg

60
New cards

Furosemide 40 mg orally is equivalent to what dose of oral bumetanide

1 mg

61
New cards

Furosemide 40 mg orally is equivalent to what dose of oral ethacrynic acid

50 mg

62
New cards

Torsemide 20 mg IV is equivalent to what dose orally?

20 mg

63
New cards

Bumetanide 1 mg IV is equivalent to what dose orally?

1 mg

64
New cards

ethacrynic acid 50 mg IV is equivalent to what dose orally?

50 mg

65
New cards

What needs to be monitored when starting hydralazine/isosorbide dinitrate/combo pill

Bp after initiation and during titration

66
New cards

When do you need to increase the dose of hydralazine/isosorbide dinitrate/combo pill

increase the dose every 2 weeks stepwise until at target dosing

67
New cards

hydralazine target dose

75 mg TID

68
New cards

Isosorbide dinitrate target dose

40 mg TID

69
New cards

BiDil target dose

2 tablets TID

70
New cards

What needs to be confirmed before starting ivabradine

confirm beta-blocker is at maximally tolerated/targeted dose and that patient is in sinus rhythm

71
New cards

When to reassess HR in patients and increase stepwise to target dosing using ivabradine

in 2-4 weeks

72
New cards

How to titrate ivabradine in patients with a HR < 50 bpm or symptoms of bradycardia

Reduce dose by 2.5 mg twice daily or discontinue if already at 2.5 mg twice daily

73
New cards

How to titrate ivabradine in patients with a HR 50-60 bpm

maintain current dose and monitor HR

74
New cards

How to titrate ivabradine in patients with a HR > 60 bpm

increase by 2.5 mg twice daily until maximum dose of 7.5 mg twice daily

75
New cards

Pearl for ivabradine

Take with food!!!!

76
New cards

Starting dose of ivabradine

2.5 mg twice daily with food

77
New cards

target dose of ivabradine

7.5 mg twice daily with food!!

78
New cards

What needs to be confirmed before starting a patient on vericiguat

Confirm EF < 45% on maximally tolerated GDMT and has worsening symptoms (recent hospitalization or need for IV diuretics) along with a negative pregnancy test

79
New cards

What needs to be monitored in patients using vericiguat

BP and CBC (anemia) during initiation and titrate

80
New cards

Pearl for vericiguat

Take with food !!

81
New cards

starting dose of vericiguat

2.5 mg daily with food

82
New cards

target dose of vericiguat

10 mg daily with food

83
New cards

Other (rare) therapy options for patients with symptomatic HFrEF and possibly arrhythmias?

digoxin (2b recommendation)

84
New cards

What is an additional therapy that can be used for patients with HF NYHA II-IV?

polyunsaturated fatty acids (PUFA) (2b recommendation)

85
New cards

What is an additional therapy that can be used for patients with HF and hyperkalemia when taking RAASi

potassium binders (2b recommendation)

86
New cards

When may digoxin be added to a medication regimen?

If patient is already on other GDMT and patient is still symptomatic

87
New cards

What are the risks associated with digoxin

cardiac arrhythmias, GI symptoms (anorexia, N/V), neurological symptoms (visual disturbances, disorientation, confusion)

88
New cards

Target plasma concentration for digoxin used in HF

0.5-0.9 ng/mL

89
New cards

Can you develop digoxin toxicity if your plasma concentration is at target (0.5-0.9 ng/mL)?

Yes 😟

90
New cards

Why should you avoid Non-DHP CCBs in HFrEF?

Can worsen EF/CO

91
New cards

Why should you avoid class IC antiarrhythmic drugs and dronedarone in HFrEF?

Increased mortality

92
New cards

Why should you avoid thiazolidinediones in HFrEF?

worsens HF symptoms and hospitalizations

93
New cards

Why should you avoid DPP-4s (saxagliptin and alogliptin) in HFrEF?

increases HF hospitalizations

94
New cards

Why should you avoid NSAIDs in HFrEF?

Worsens HF symptoms (fluid overload)